BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21944773)

  • 1. Late breast metastasis from resected lung cancer diagnosed by epidermal growth factor receptor gene mutation.
    Fukumoto K; Usami N; Okasaka T; Kawaguchi K; Okagawa T; Suzuki H; Yokoi K
    Lung Cancer; 2011 Nov; 74(2):352-3. PubMed ID: 21944773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
    Suehisa H; Toyooka S; Hotta K; Uchida A; Soh J; Fujiwara Y; Matsuo K; Ouchida M; Takata M; Kiura K; Date H
    J Clin Oncol; 2007 Sep; 25(25):3952-7. PubMed ID: 17761979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
    Takuwa T; Tanaka F; Yoneda K; Torii I; Hashimoto M; Okumura Y; Matsumoto S; Kondo N; Hasegawa S
    Lung Cancer; 2010 Jun; 68(3):498-500. PubMed ID: 20307913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.
    Ikeda K; Nomori H; Mori T; Sasaki J; Kobayashi T
    Ann Thorac Surg; 2008 Apr; 85(4):1430-2. PubMed ID: 18355544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
    Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
    Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.
    Schwab R; Pinter F; Moldavy J; Papay J; Strausz J; Kopper L; Keri G; Pap A; Petak I; Oreskovich K; Mangel L
    J Clin Oncol; 2005 Oct; 23(30):7736-8. PubMed ID: 16234532
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
    Tam IY; Chung LP; Suen WS; Wang E; Wong MC; Ho KK; Lam WK; Chiu SW; Girard L; Minna JD; Gazdar AF; Wong MP
    Clin Cancer Res; 2006 Mar; 12(5):1647-53. PubMed ID: 16533793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation.
    Ohtsuka K; Ohnishi H; Kurai D; Matsushima S; Morishita Y; Shinonaga M; Goto H; Watanabe T
    J Clin Oncol; 2011 Mar; 29(8):e191-2. PubMed ID: 21172876
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.
    Haneda H; Sasaki H; Shimizu S; Endo K; Suzuki E; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Lung Cancer; 2006 Apr; 52(1):47-52. PubMed ID: 16503085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications.
    Piacentini F; Rossi G; Casali C; Cadioli A; Barbieri E; Guarneri V
    Lung Cancer; 2011 Oct; 74(1):145-8. PubMed ID: 21767893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC; Chow AS; Au JS
    Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma.
    Nakamura H; Mochizuki A; Shinmyo T; Ando K; Kurimoto N; Yokote K; Takagi M
    Anticancer Res; 2010 Dec; 30(12):5233-7. PubMed ID: 21187519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequacy and complications of computed tomography-guided core needle biopsy on non-small cell lung cancers for epidermal growth factor receptor mutations demonstration: 18-gauge or 20-gauge biopsy needle.
    Cheung YC; Chang JW; Hsieh JJ; Lin G; Tsai YH
    Lung Cancer; 2010 Feb; 67(2):166-9. PubMed ID: 19450892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers.
    Chang YL; Wu CT; Shih JY; Lee YC
    Ann Surg Oncol; 2011 Feb; 18(2):543-50. PubMed ID: 20811949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between hormone receptor expression and epidermal growth factor receptor mutation in patients operated on for non-small cell lung cancer.
    Sun HB; Zheng Y; Ou W; Fang Q; Li P; Ye X; Zhang BB; Yang H; Wang SY
    Ann Thorac Surg; 2011 May; 91(5):1562-7. PubMed ID: 21524465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.
    Yuan S; Yu SL; Chen HY; Hsu YC; Su KY; Chen HW; Chen CY; Yu CJ; Shih JY; Chang YL; Cheng CL; Hsu CP; Hsia JY; Lin CY; Wu G; Liu CH; Wang CD; Yang KC; Chen YW; Lai YL; Hsu CC; Lin TC; Yang TY; Chen KC; Hsu KH; Chen JJ; Chang GC; Li KC; Yang PC
    J Clin Oncol; 2011 Sep; 29(25):3435-42. PubMed ID: 21810691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications.
    Prudkin L; Wistuba II
    Ann Diagn Pathol; 2006 Oct; 10(5):306-15. PubMed ID: 16979526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
    Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
    Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.